We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+9.04%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$661M
AUM Growth
+$34.1M
Cap. Flow
-$6.85M
Cap. Flow %
-1.04%
Top 10 Hldgs %
25.72%
Holding
101
New
10
Increased
24
Reduced
44
Closed
5

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$12.3M
2
ABMD
Abiomed Inc
ABMD
+$12.2M
3
WBA
Walgreens Boots Alliance
WBA
+$11.2M
4
CVS icon
CVS Health
CVS
+$8.13M
5
BHC icon
Bausch Health
BHC
+$7.75M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$8.33M
2
ALKS icon
Alkermes
ALKS
+$6.79M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.92M
4
HCA icon
HCA Healthcare
HCA
+$5.86M
5
EW icon
Edwards Lifesciences
EW
+$5.84M

Sector Composition

Rank Sector Weight
1 Healthcare 92.69%
2 Financials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYBX
101
DELISTED
CYBERONICS INC
CYBX
– –
-57,000
Closed -$3.46M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Rhenman & Partners Asset Management held 101 positions worth $661M, up 5.4% from $627M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rhenman & Partners Asset Management's Q4 2015 filing shows 10 new, 24 increased, 44 reduced and 5 closed positions. Its largest new stake was Walgreens Boots Alliance: 132,000 shares worth $11.2M. The largest sale was Amgen, an estimated $8.33M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials.

  • Rhenman & Partners Asset Management's largest Q4 2015 buy was Walgreens Boots Alliance: 132,000 shares worth $11.2M.
  • Rhenman & Partners Asset Management added most to Perrigo in Q4 2015, an estimated $12.3M increase.
  • Rhenman & Partners Asset Management's biggest Q4 2015 reduction was Amgen, cutting an estimated $8.33M.
  • Rhenman & Partners Asset Management fully exited Merck in Q4 2015, selling an estimated $4.94M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 26% of its $661M portfolio in Q4 2015.
  • Rhenman & Partners Asset Management opened 10 new positions and closed 5 in Q4 2015.
  • Rhenman & Partners Asset Management's portfolio value rose 5.4% quarter-over-quarter to $661M.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2015, filed 19 Jan 2016.